Contract Specifications
See MoreContract
N/A
Contract Size
N/A
Tick Size
N/A
Trading Hours
N/A
Exchange
CBOT
Point Value
$50
Expiration Date
11/27/24 (11 days)
KC HRW Wheat TAS Dec '24 (TKEZ24)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CBOT]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Get Realtime - Quotes and Charts for Futures Traders. Learn More >>
Free Barchart Webinars! Live educational sessions using site features to explore today's markets.
Most Recent Stories
More News Intellia Therapeutics Reports Promising Phase 1 Trial Results for Nexiguran Ziclumeran in ATTR Amyloidosis
Intellia Therapeutics announces positive Phase 1 trial results for nex-z in ATTR amyloidosis, indicating significant TTR reduction and disease stabilization.Quiver AI SummaryIntellia Therapeutics announced...
Cytokinetics Presents New Data on Omecamtiv Mecarbil from GALACTIC-HF Trial at AHA Scientific Sessions 2024
Cytokinetics presented new analyses on omecamtiv mecarbil's efficacy in heart failure at the AHA Scientific Sessions 2024.Quiver AI SummaryCytokinetics, Incorporated announced new findings from post-hoc...
Cytokinetics Presents Promising New Data on Aficamten for Hypertrophic Cardiomyopathy at AHA Scientific Sessions 2024
New analyses show Aficamten improves oxygen uptake recovery, quality of life, and reduces septal reduction therapy eligibility in HCM patients.Quiver AI SummaryCytokinetics, Incorporated announced new...
Educational and Actionable information using Fibonacci and W.D. Gann analysis.
Nuclear stocks are gaining momentum, and Vistra is leading the charge. With investments in zero-carbon assets and a bullish outlook from analysts, the company is capitalizing on the nuclear sector's resurgence...
December Lean Hogs has increased by over 36% since July. On Thursday, Lean Hogs dropped (2.2%) and broke through the upward trendline. This was confirmed on Friday when the market again closed below...
With Realty Income’s shares lagging behind the broader market over the past year, Wall Street analysts remain cautiously optimistic about its prospects.
Although CELH stock will likely represent a long-term value play, temporary uncertainties over the beverage industry present a compelling short trade.
What’s behind this analyst’s sudden shift to a more cautious stance on Devon Energy?
